GK
George Kemble sold $201K of SGMT stock
George Kemble, Dir of Sagimet Biosciences Inc. (SGMT), sold 20,206 shares of SGMT stock worth $201K, per an SEC Form 4 filed Aug 12, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 11, 2026, 1 day before it was made public.
SGMT has moved +3.5% since the trade date, from $9.52 to $9.85 (Nov 17, 2026 close).
- Traded
- Aug 11, 2026
- Disclosed
- Aug 12, 2026
- Filing delay
- 1 day
- Price since
- +3.5%
- Role
- Dir
- Source
- SEC Form 4